1NO9 | Hydrolase Hydrolase Inhibitor | date | Jan 16, 2003 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Design Of Weakly Basic Thrombin Inhibitors Incorporating Nov Binding Functions: Molecular And X-Ray Crystallographic Stu | ||||||||||||||
authors | G.De Simone, V.Menchise, S.Omaggio, C.Pedone, A.Scozzafava, C.T.S | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Alpha Thrombin Chain: L Fragment: Light Chain Ec: 3.4.21.5 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Plasma | ||||||||||||||
Molecule: Alpha Thrombin Chain: H Fragment: Heavy Chain Ec: 3.4.21.5 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Plasma | ||||||||||||||
Molecule: Hirugen Chain: I Fragment: Chain I Synonym: N-Acetylhirudin 53 - 64 With Sulfato-Tyr 63, Hirud Fragments; Engineered: Yes |
Synthetic: Yes Organism_scientific: Hirudo Medicinalis Organism_taxid: 6421 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 Å | ||||||||||||
ligand | 4ND, NAG, TYS | enzyme | Hydrolase E.C.3.4.21.5 BRENDA | ||||||||||||
related structures | by homologous chain: 1K21, 1TA6, 1XMN | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies., De Simone G, Menchise V, Omaggio S, Pedone C, Scozzafava A, Supuran CT, Biochemistry 2003 Aug 5;42(30):9013-21. PMID:12885234 |
Data retrieval |
View 1NO9 in 3D |
Visual 3D analysis of 1NO9 |
Structure-derived information |
- Domain d1no9.1, region L:,H [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1NO9 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |